DALLAS, March 29, 2018 -- eTrueNorth, the U.S. based healthcare technology & compliance solution provider for CLIA-waived laboratories, is the only provider that certifies regulatory compliance in the biometric screening industry. eTrueNorth is pleased to announce that Onsite Health Diagnostics has successfully passed all of the requirements of the CLIA-Waived Laboratory Regulatory Compliance Audit.
Kyle Alexander, CEO of Onsite Health Diagnostics; “As we have for 15 years, Onsite Health Diagnostics continues to prioritize compliance to regulations that apply to the biometric screening industry. Until now, there was no solution in the market to certify that biometric screening vendors meet the federal, state & county regulations that apply to all CLIA-waived laboratories. NCQA and URAC offer accreditation programs for wellness companies; however, there has been no similar distinction applicable to biometric screenings or the companies that perform them. eTrueNorth is filling the gap and giving our industry and its clients proof of regulatory compliance. We are delighted to be the first to meet all of the audit requirements.”
“eTrueNorth worked closely with Onsite Health Diagnostics and performed a 50-state review of the biometric screening company’s compliance to national, state and county regulatory requirements and ensured proper documentation was present. The audit covered such items as permits, standing physician orders and sufficient quality control documentation across 50 states,” said Coral May, President of eTrueNorth. “Employers who purchase point-of-care testing now have proof that Onsite Health Diagnostic’s biometric screenings are compliant with all applicable regulations.”
eTrueNorth’s vision is a world where high-quality, cost-efficient and accessible point-of-care testing becomes an integral part of healthcare delivery in every community. “This is an example of how eTrueNorth is working to raise the level of credibility of onsite biometric screening companies and pharmacies that provide point-of-care testing” said May. “Biometric screening companies and pharmacies that use CLIA-waived devices and their clients are very concerned about regulatory compliance and accuracy. The CLIA-Waived Laboratory Regulatory Compliance Audit is the way to demonstrate an organization’s commitment to quality test results.”
About Onsite Health Diagnostics
Onsite Health Diagnostics is the leading, most technologically advanced provider of employee health screenings, outcomes-based incentive management, and workforce health analytics to some of the largest employers, corporate wellness providers, and health insurance companies in the United States.
About eTrueNorth
eTrueNorth is the leading organization focused on elevating expectations of, and opportunities for, CLIA waived laboratories. The company’s goal is to improve access, quality and lower cost by fitting healthcare into everyday life and leveraging the accessibility of retail pharmacies. eTrueNorth is expanding the scope of services available to consumers and enhancing the pharmacy’s value as a key participant in a multi-disciplinary healthcare delivery model. To learn more, visit eTrueNorth.com or contact CV Abdallah at (315) 374-7792 or [email protected].


BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Apple Restores Telegram to App Store After Content Policy Violation
Telegram Restored on Apple App Store After Temporary Removal
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 



